Diagnostic Histopathology
Volume 15, Issue 11 , Pages 501-509 , November 2009

Renal tumours of childhood: an overview

References 

  1. Birch JM, Breslow N. Epidemiologic features of Wilms tumor. Hematol Oncol Clin North Am. 1995;9:1157–1178
  2. Vujanic GM, Sandstedt B, Kelsey A, Sebire NJ. Central pathology review in multicenter trials and studies. Lessons from the Nephroblastoma trials. Cancer. 2009;115:1977–1983
  3. Pritchard-Jones K, Pritchard J. Success of clinical trials in childhood Wilms' tumour around the world. Lancet. 2004;364:1468–1470
  4. Vujanic GM, Kelsey A, Mitchell C, Shannon R, Gornall P. The role of biopsy in the diagnosis of renal tumors of childhood: results of the UKCCSG Wilms Tumor Study 3. Med Pediatr Oncol. 2003;40:18–22
  5. Vujanic GM, Sandstedt B, Harms D, Kelsey A, Leuschner I, de Kraker J. Revised International Society of Paediatric Oncology (SIOP) working classification of renal tumors of childhood. Med Pediatr Oncol. 2002;38:79–82
  6. COG Low and standard risk favorable histology Wilms tumor protocol AREN0532, 2007.
  7. Vujanic GM, Harms D, Bohoslavsky R, Leuschner I, de Kraker J, Sandstedt B. Nonviable tumor tissue should not upstage Wilms' tumors from stage I to stage II: a report from the SIOP 93-01 Nephroblastoma trial and study. Pediatr Develop Pathol. 2009;12:111–115
  8. SIOP 2001 Nephroblastoma Trial and Study Protocol, 2001.
  9. Ritchey ML, Azizkhan RG, Beckwith JB, Hrabovsky EE, Haase GM. Neonatal Wilms' tumor. J Pediatr Surg. 1995;30:856–859
  10. Mitry E, Ciccolallo L, Coleman MP, Gatta G, Pritchard-Jones K. Incidence of and survival from Wilms' tumour in adults in Europe: data from the EUROCARE study. Eur J Cancer. 2006;42:2363–2368
  11. Coppes MJ, de Kraker J, Van Dijken PJ, et al. Bilateral Wilms' tumor: long-term survival and some epidemiological features. J Clin Oncol. 1989;7:310–315
  12. Ruteshouser EC, Huff V. Familial Wilms tumor. Am J Med Genet C Semin Med Genet. 2004;129:29–34
  13. Coppes MJ, Wilson PC, Weitzman S. Extrarenal Wilms' tumor: staging, treatment, and prognosis. J Clin Oncol. 1991;9:167–174
  14. Scott RH, Stiller CA, Walker L, Rahman N. Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour. J Med Genet. 2006;43:705–715
  15. Weirich A, Leuschner I, Harms D, et al. Clinical impact of histologic subtypes in localized non-anaplastic nephroblastoma treated according to the trial and study SIOP-9/GPOH. Ann Oncol. 2001;12:311–319
  16. Pritchard-Jones K, Kelsey A, Vujanic G, Imeson J, Hutton C, Mitchell C. Older age is an adverse prognostic factor in stage I, favorable histology Wilms' tumor treated with vincristine monochemotherapy: a study by the United Kingdom Children's Cancer Study Group, Wilm's Tumor Working Group. J Clin Oncol. 2003;21:3269–3275
  17. Dome JS, Cotton CA, Perlman EJ, et al. Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study. J Clin Oncol. 2006;24:2352–2358
  18. Faria P, Beckwith JB, Mishra K, et al. Focal versus diffuse anaplasia in Wilms tumor -new definitions with prognostic significance: a report from the National Wilms Tumor Study Group. Am J Surg Pathol. 1996;20:909–920
  19. Bardeesy N, Falkoff D, Petruzzi MJ, et al. Anaplastic Wilms' tumour, a subtype displaying poor prognosis, harbours p53 gene mutations. Nat Genet. 1994;7:91–97
  20. Breslow NE, Beckwith JB, Perlman EJ, Reeve AE. Age distributions, birth weights, nephrogenic rests, and heterogeneity in the pathogenesis of Wilms tumor. Pediatr Blood Cancer. 2006;47:260–267
  21. Fukuzawa R, Reeve AE. Molecular pathology and epidemiology of nephrogenic rests and Wilms tumors. J Pediatr Hematol Oncol. 2007;29:589–594
  22. Dome JS, Coppes MJ. Recent advances in Wilms tumor genetics. Curr Opin Pediatr. 2002;14:5–11
  23. Pritchard-Jones K, Vujanic G. Multiple pathways to Wilms tumor: how much is genetic?. Pediatr Blood Cancer. 2006;47:232–234
  24. Rivera MN, Kim WJ, Wells J, et al. An X chromosome gene, WTX, is commonly inactivated in Wilms tumor. Science. 2007;315:642–645
  25. Grundy PE, Breslow NE, Li S, et al. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group. J Clin Oncol. 2005;23:7312–7321
  26. Joshi VV, Beckwith JB. Multilocular cyst of the kidney (cystic nephroma) and cystic, partially differentiated nephroblastoma. Terminology and criteria for diagnosis. Cancer. 1989;64:466–479
  27. Boman F, Hill DA, Williams GM, et al. Familial association of pleuropulmonary blastoma with cystic nephroma and other renal tumors: a report from the International Pleuropulmonary Blastoma Registry. J Pediatr. 2006;149:850–854
  28. Bouron-Dal Soglio D, Harvey I, Yazbeck S, Rypens F, Oligny LL, Fournet JC. An association of pleuropulmonary blastoma and cystic nephroma: possible genetic association. Pediatr Dev Pathol. 2006;9:61–64
  29. van den Heuvel-Eibrink MM, Grundy P, Graf N, et al. Characteristics and survival of 750 children diagnosed with a renal tumor in the first seven months of life: a collaborative study by the SIOP/GPOH/SFOP, NWTSG, and UKCCSG Wilms Tumor Study Groups. Pediatr Blood Cancer. 2008;50:1130–1134
  30. Murphy WM, Grignon DJ, Perlman EJ. Kidney tumors in children. In: Tumors of the kidney, bladder, and urinary structures. Atlas of tumor pathology, 4th Series. Fascicle 1:Washington, DC: Armed Forces Institute of Pathology; 2004;p. 57–64
  31. Knezevich SR, Garnett MJ, Pysher TJ, Beckwith JB, Grundy PE, Sorensen PH. ETV6-NTRK3 gene fusions and trisomy 11 establish a histogenetic link between mesoblastic nephroma and congenital fibrosarcoma. Cancer Res. 1998;58:5046–5048
  32. Furtwaengler R, Reinhard H, Leuschner I, et al. Mesoblastic nephroma - a report from the Gesellschaft fur Padiatrische Onkologie und Hamatologie (GPOH). Cancer. 2006;106:2275–2283
  33. Beckwith JB. Letter to editor. Pediatr Pathol. 1993;13:886–887
  34. Argani P, Perlman EJ, Breslow NE, et al. Clear cell sarcoma of the kidney: a review of 351 cases from the National Wilms Tumor Study Group Pathology Center. Am J Surg Pathol. 2000;24:4–18
  35. Schuster AE, Schneider DT, Fritsch MK, et al. Genetic and genetic expression analyses of clear cell sarcoma of the kidney. Lab Invest. 2003;83:1293–1299
  36. Brownlee NA, Perkins LA, Stewart W, et al. Recurring translocation (10;17) and deletion (14q) in clear cell sarcoma of the kidney. Arch Pathol Lab Med. 2007;131:446–451
  37. Bonadio J, Perlman EJ. Immunohistochemical analysis of 61 clear cell sarcomas on the kidney for a panel including NGFR and CD99. Book of Abstracts from the Society for Pediatric Pathology Annual Meeting, 2008: A26.
  38. Seibel NL, Li S, Breslow NE, et al. Effect of duration of treatment on treatment outcome for patients with clear-cell sarcoma of the kidney: a report from the National Wilms' Tumor Study Group. J Clin Oncol. 2004;22:468–473
  39. Weeks DA, Beckwith JB, Mierau GW, Luckey DW. Rhabdoid tumor of kidney. A report of 111 cases from the National Wilms' Tumor Study Pathology Center. Am J Surg Pathol. 1989;13:439–458
  40. Vujanic GM, Sandstedt B, Harms D, Boccon-Gibod L, Delemarre JF. Rhabdoid tumour of the kidney: a clinicopathological study of 22 patients from the International Society of Paediatric Oncology (SIOP) nephroblastoma file. Histopathology. 1996;28:333–340
  41. Hoot AC, Russo P, Judkins AR, Perlman EJ, Biegel JA. Immunohistochemical analysis of hSNF5/INI1 distinguishes renal and extra-renal malignant rhabdoid tumors from other pediatric soft tissue tumors. Am J Surg Pathol. 2004;28:1485–1491
  42. Tomlinson GE, Breslow NE, Dome J, et al. Rhabdoid tumor of the kidney in the National Wilms' Tumor Study: age at diagnosis as a prognostic factor. J Clin Oncol. 2005;23:7641–7645
  43. Argani P, Beckwith JB. Metanephric stromal tumor. Report of 31 cases of a distinctive pediatric renal neoplasm. Am J Surg Pathol. 2000;24:917–926
  44. Arroyo MR, Green DM, Perlman EJ, Beckwith JB, Argani P. The spectrum of metanephric adenofibroma and related lesions. Clinicopathologic study of 25 cases from the National Wilms Tumor Strudy Group Pathology Centre. Am J Surg Pathol. 2001;25:433–444
  45. Davis CJ, Barton JH, Sesterhenn IA, Mostofi FK. Metanephric adenoma. Clinicopathological study of fifty patients. Am J Surg Pathol. 1995;19:1101–1114
  46. Argani P. Metanephric neoplasms: the hyperdifferentiated, benign end of the Wilms tumor spectrum?. Clin Lab Med. 2005;25:379–392
  47. Argani P, Olgac S, Tickoo SK, et al. Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum. Am J Surg Pathol. 2007;31:1149–1160
  48. Bruder E, Passera O, Harms D, et al. Morphologic and molecular characterization of renal cell carcinoma in children and young adults. Am J Surg Pathol. 2004;28:1117–1132
  49. Argani P. The evolving story of renal translocation carcinomas. Am J Clin Pathol. 2006;126:332–334
  50. Argani P, Ladanyi M. Translocation carcinomas of the kidney. Clin Lab Med. 2005;25:363–378
  51. Eble JN, Sauter G, Epstein JI, Sesterhenn IA. Tumours of the urinary system and male genital organs: pathology and genetics. World Health Organisation classification of tumours. Lyon: IARC; 2004;
  52. Argani P, Lal P, Hutchinson B, Lui MY, Reuter VE, Ladanyi M. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay. Am J Surg Pathol. 2003;27:750–761
  53. Argani P, Lae M, Hutchinson B, et al. Renal carcinomas with the t(6;11) (p21;q12): clinicopathologic features and demonstration of the specific alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DNA PCR. Am J Surg Pathol. 2005;29:230–240
  54. Argani P, Ladanyi M. Recent advances in pediatric renal neoplasia. Adv Anat Pathol. 2003;10:243–260
  55. Argani P, Lae M, Ballard ET, et al. Translocation carcinomas of the kidney after chemotherapy in childhood. J Clin Oncol. 2006;24:1529–1534
  56. Renshaw AA, Granter SR, Fletcher JA, Kozakewich HP, Corless CL, Perez-Atayde AR. Renal cell carcinomas in children and young adults: increased incidence of papillary architecture and unique subtypes. Am J Surg Pathol. 1999;23:795–802
  57. Davis CJ, Mostofi FK, Sesterhenn IA. Renal medullary carcinoma. The seventh sickle cell nephropathy. Am J Surg Pathol. 1995;19:1–11
  58. Swartz MA, Karth J, Schneider DT, Rodriguez R, Beckwith JB, Perlman EJ. Renal medullary carcinoma: clinical, pathologic, immunohistochemical, and genetic analysis with pathogenetic implications. Urology. 2002;60:1083–1089
  59. Medeiros LJ, Palmedo G, Krigman HR, Kovacs G, Beckwith JB. Oncocytoid renal cell carcinoma after neuroblastoma: a report of four cases of a distinct clinicopathologic entity. Am J Surg Pathol. 1999;23:772–780
  60. Parham DM, Roloson GJ, Feely M, Green DM, Bridge JA, Beckwith JB. Primary malignant neuroepithelial tumors of the kidney: a clinicopathologic analysis of 146 adult and pediatric cases from the National Wilms' Tumor Study Group Pathology Center. Am J Surg Pathol. 2001;25:133–146
  61. Argani P, Faria PA, Epstein JI, et al. Primary renal synovial sarcoma: molecular and morphologic delineation of an entity previously included among embryonal sarcomas of the kidney. Am J Surg Pathol. 2000;24:1087–1096
  62. Wang LL, Perlman EJ, Vujanic GM, et al. Desmoplastic small round cell tumor of the kidney in childhood. Am J Surg Pathol. 2007;31:576–584
  63. Vujanic GM, Kelsey A, Perlman EJ, Sandstedt B, Beckwith JB. Anaplastic sarcoma of the kidney: a clinicopathologic study of 20 cases of a new entity with polyphenotypic features. Am J Surg Pathol. 2007;31:1459–1468
  64. Hara N, Kawaguchi M, Murayama S, Maruyama R, Tanikawa T, Takahashi K. Mixed epithelial and stromal tumor of the kidney in a 12-year-old girl. Pathol Int. 2005;55:670–676

PII: S1756-2317(09)00158-3

doi: 10.1016/j.mpdhp.2009.08.002

Diagnostic Histopathology
Volume 15, Issue 11 , Pages 501-509 , November 2009

Article Tools

* Image Usage & Resolution